DANIEL MEDINA to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications DANIEL MEDINA has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.153
-
Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs. Cancer Lett. 2014 Aug 01; 350(1-2):52-60.
Score: 0.083
-
The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res. 2004; 6(6):240-5.
Score: 0.043
-
Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells. PLoS One. 2018; 13(3):e0194913.
Score: 0.027